KRSNAA
Krsnaa Diagnostics Limited (KRSNAA) Stock Analysis
Krsnaa Diagnostics Limited operates diagnostic laboratories offering pathology and imaging services in multiple states. It partners with governments and hospitals on affordable testing programs. The company earns from test volumes and PPP contracts. It is a listed diagnostics chain.
Healthcare › Diagnostics & Research
₹533.30
-0.41% 1W | -32.40% 52W
Market Cap
1.8k CR
P/E Ratio
18
52W High
₹838
52W Low
₹515
Div. Yield
0.38%
Beta
0
50 DMA
₹553.2
200 DMA
₹588.6
Profit Margin
11.6%
Inst. Own.
13.5%
⚡ APPROACHING SUPPORT
⚡ APPROACHING SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 140 | 155 | 158 | 166 | 170 | 186 | 175 | 186 | 193 | 206 | 181 | 193 | 236 |
| Expenses | 108 | 124 | 121 | 123 | 128 | 137 | 129 | 133 | 142 | 147 | 135 | 138 | 178 |
| Operating Profit | 31 | 32 | 37 | 44 | 43 | 49 | 45 | 53 | 51 | 59 | 46 | 55 | 58 |
| OPM % | 22% | 20% | 24% | 26% | 25% | 27% | 26% | 28% | 27% | 29% | 26% | 28% | 25% |
| Other Income | 4 | 4 | 4 | 4 | 7 | 5 | 9 | 4 | 4 | 4 | 4 | 32 | 7 |
| Interest | 2 | 3 | 4 | 7 | 5 | 6 | 6 | 7 | 6 | 8 | 8 | 12 | 15 |
| Depreciation | 16 | 19 | 21 | 18 | 21 | 22 | 23 | 22 | 22 | 24 | 23 | 23 | 28 |
| Profit before tax | 18 | 13 | 16 | 23 | 23 | 25 | 25 | 29 | 27 | 32 | 20 | 52 | 22 |
| Tax % | 18% | 22% | 19% | 17% | 23% | 23% | 24% | 28% | 25% | 24% | 23% | 19% | 26% |
| Net Profit | 15 | 10 | 13 | 19 | 18 | 20 | 19 | 21 | 21 | 24 | 15 | 42 | 17 |
| EPS in Rs | 4.66 | 3.34 | 4.02 | 5.80 | 5.55 | 6.07 | 6.01 | 6.40 | 6.33 | 7.38 | 4.70 | 12.86 | 5.10 |
| Metric | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 39 | 61 | 455 | 487 | 620 | 717 | 773 | 815 |
| Expenses | 30 | 42 | 324 | 365 | 475 | 527 | 561 | 597 |
| Operating Profit | 9 | 19 | 132 | 122 | 144 | 190 | 212 | 218 |
| OPM % | 23% | 31% | 29% | 25% | 23% | 27% | 27% | 27% |
| Other Income | 3 | 2 | 15 | 19 | 17 | 26 | 43 | 47 |
| Interest | 9 | 9 | 18 | 8 | 16 | 25 | 34 | 43 |
| Depreciation | 6 | 12 | 41 | 54 | 75 | 88 | 90 | 97 |
| Profit before tax | -3 | 0 | 87 | 80 | 70 | 103 | 130 | 125 |
| Tax % | 49% | 180% | 21% | 23% | 19% | 24% | 22% | |
| Net Profit | -5 | -0 | 68 | 62 | 57 | 78 | 101 | 97 |
| EPS in Rs | -4.78 | -0.07 | 21.78 | 19.78 | 17.60 | 24.04 | 31.27 | 30.04 |
| Dividend Payout % | 0% | 0% | 11% | 14% | 14% | 11% | 6% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 17.0% | – | 35.0% |
| Profit CAGR | 18.0% | – | 37.0% |
Shareholding Pattern
Promoters27.11%
FIIs3.66%
DIIs14.96%
Public54.27%
Promoters27.11%
FIIs4.17%
DIIs13.85%
Public54.86%
Promoters27.11%
FIIs3.91%
DIIs13.89%
Public55.09%
Promoters27.11%
FIIs4.28%
DIIs14.51%
Public54.08%
Promoters27.11%
FIIs3.84%
DIIs14.50%
Public54.55%
Promoters27.79%
FIIs3.39%
DIIs18.49%
Public50.33%
Promoters27.03%
FIIs3.34%
DIIs15.37%
Public54.27%
Promoters27.24%
FIIs3.55%
DIIs14.26%
Public54.94%
Promoters27.11%
FIIs3.91%
DIIs13.89%
Public55.09%
Promoters27.11%
FIIs3.84%
DIIs14.50%
Public54.55%
KRSNAA
Holdings Analysis
Key strengths & risk signals
61
Overall
68
Fundamental
55
Technical
Risks (4)
TOO MUCH PUBLIC HOLDING! 46.74% public ownership - higher volatility risk.
POOR YEAR! Stock declined 32.4% in the last year.
WEAK POSITION! Current price (533.3) is below both moving averages.
WEAK! Trading at 5.7% of 52W range - near yearly lows.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH SENTIMENT! In last 30 days: 15 up days, 14 down days. Avg volume on up days: 288,688 vs down days: 44,453. Ratio: 6.49x
NEUTRAL! RSI at 43.4 - balanced momentum.
MARKET ALIGNED! Beta of 1.00 - moves with the market.
Fundamental & Technical Analysis
61Overall
68Fundamental
55Technical
Fundamental Breakdown
Growth Quality
26/30
Revenue CAGR: 16.6% (VERY GOOD, 13/15). Profit CAGR: 17.8% (VERY GOOD, 13/15).
Profit Margin
5/10
DECENT EFFICIENCY! 11.6% profit margin - acceptable profitability.
PEG Valuation
9/10
FAIRLY VALUED! PEG of 1.01 indicates reasonable valuation.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.38% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 46.74% public ownership - higher volatility risk.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (553.2) is below 200-day average (588.6) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (533.3) is below both moving averages.
Trend Pattern
10/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
0/10
POOR YEAR! Stock declined 32.4% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 15 up days, 14 down days. Avg volume on up days: 288,688 vs down days: 44,453. Ratio: 6.49x
RSI
3/5
NEUTRAL! RSI at 43.4 - balanced momentum.
52W Range
1/5
WEAK! Trading at 5.7% of 52W range - near yearly lows.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.4% (1 week), 0.6% (1 month), 1.2% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
KRSNAA
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-05-29 | Concall PDF | |
| Q3FY262026-02-11 | Concall PDF | |
| Q2FY262025-11-14 | Concall PDF |
Peer Comparison
Healthcare · Diagnostics & Research · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRSNAA | ₹533.30 | 18 | 11.6% | 16.6% | 17.8% | -32.4% | 61 | APPROACHING SUPPORT | -19.0% | -60.2% | +22.0% | +22.3% |
| SURAKSHA | ₹306.70 | 44.6 | 11.0% | 17.7% | 70.3% | +5.9% | 78 | BREAKDOWN | +38.3% | +106.3% | +20.7% | +7.6% |
| VIMTALABS | ₹522.50 | 29.6 | 18.9% | 8.9% | 17.2% | -21.8% | 57 | BREAKDOWN | +11.1% | -0.5% | +11.8% | -0.1% |
| THYROCARE | ₹485.20 | 44 | 20.1% | 16.7% | 36.2% | +17.6% | 87 | BREAKDOWN | +34.2% | +10.8% | +24.4% | +7.1% |
| METROPOLIS | ₹530.40 | 54.6 | 11.8% | 12.8% | 10.0% | +7.9% | 67 | BREAKDOWN | +25.7% | +11.4% | +16.6% | +6.0% |
| VIJAYA | ₹1,381.70 | 76 | 21.9% | 21.0% | 26.9% | +41.3% | 74 | BREAKDOWN | +37.6% | +10.9% | +22.8% | +5.3% |
| SYNGENE | ₹386.10 | 70.3 | 6.1% | 5.4% | -12.0% | -40.0% | 57 | BOUNCE FROM SUPPORT | -110.4% | -106.1% | -15.8% | -29.0% |
| SAILIFE | ₹1,389.40 | 82.1 | 16.1% | 21.3% | 226.9% | +60.0% | 70 | BREAKDOWN | +21.2% | -29.7% | +11.7% | -7.9% |
Data from TradeAlone · Updated daily
